The place of polymer prodrugs in cancer therapy

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.5, Iss.4, 2000-12, pp. : 457-463

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enzyme and Proton-Activated Prodrugs for a Selective Cancer Therapy

Current Pharmaceutical Design, Vol. 9, Iss. 26, 2003-10 ,pp. : 2155-2175

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors and Prodrugs Targeting CYP1: A Novel Approach in Cancer Prevention and Therapy

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. : 519-552

Bentham Science Publishers

Access to resources Recommend Favorite

Prodrugs in Photodynamic Anticancer Therapy

Current Pharmaceutical Design, Vol. 17, Iss. 32, 2011-11 ,pp. : 3548-3559

Bentham Science Publishers

Access to resources Recommend Favorite

Prodrugs of Anthracyclines in Cancer Chemotherapy

Current Medicinal Chemistry, Vol. 13, Iss. 5, 2006-03 ,pp. : 477-523

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Use of Radiolabeled Glucuronide Prodrugs with Auger and/or Alpha Emitters in Combined Chemo- and Radio-Therapy of Cancer

Current Pharmaceutical Design, Vol. 6, Iss. 11, 2000-07 ,pp. : 1127-1142

Bentham Science Publishers

Access to resources Recommend Favorite